首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   53篇
  免费   9篇
儿科学   2篇
基础医学   11篇
临床医学   1篇
内科学   4篇
神经病学   4篇
特种医学   1篇
外科学   16篇
综合类   2篇
预防医学   14篇
药学   3篇
肿瘤学   4篇
  2022年   1篇
  2021年   1篇
  2019年   1篇
  2018年   3篇
  2017年   2篇
  2016年   2篇
  2015年   3篇
  2014年   2篇
  2013年   4篇
  2012年   3篇
  2011年   7篇
  2010年   4篇
  2009年   1篇
  2008年   2篇
  2007年   4篇
  2006年   2篇
  2005年   4篇
  2004年   3篇
  2003年   2篇
  2002年   3篇
  2000年   1篇
  1999年   1篇
  1993年   2篇
  1992年   1篇
  1991年   1篇
  1982年   1篇
  1979年   1篇
排序方式: 共有62条查询结果,搜索用时 571 毫秒
1.
Two boys aged 13 and 7 years, displayed chronic coughing, dyspnoea on exertion, anorexia, weight loss, and fatigue. At first a diagnosis of asthma was made. However, a correct interpretation of anamnestic and clinical features, laboratory findings and radiographic results led to the diagnosis of 'pigeon breeder's disease' in both cases. Both patients recovered after drug treatment and avoidance of re-exposure to pigeon antigen.  相似文献   
2.
Hydrogenase (hydrogen:ferricytochrome c3 oxidoreductase, EC 1.12.2.1) from Desulfovibrio vulgaris was encapsulated in reversed micelles with cetyltrimethylammonium bromide as surfactant and a chloroform/octane mixture as solvent. Reducing equivalents for hydrogenase-catalyzed hydrogen production were provided by vectorial photosensitized electron transfer from a donor (thiophenol) in the organic phase through a surfactant-Ru2+ sensitizer located in the interphase to methyl viologen concentrated in the aqueous core of the reversed micelle. The results show that reversed micelles provide a microenvironment that (i) stabilizes hydrogenase against inactivation and (ii) allows an efficient vectorial photosensitized electron and proton flow from the organic phase to hydrogenase in the aqueous phase.  相似文献   
3.

In recent years, there has been an increasing focus on routine outcome monitoring (ROM) to provide feedback on patient progress during mental health treatment, with some systems also predicting the expected treatment outcome. The aim of this study was to elicit patients’ and psychologists’ preferences regarding how ROM system-generated feedback reports should display predicted treatment outcomes. In a discrete-choice experiment, participants were asked 12–13 times to choose between two ways of displaying an expected treatment outcome. The choices varied in four different attributes: representation, outcome, predictors, and advice. A conditional logistic regression was used to estimate participants’ preferences. A total of 104 participants (68 patients and 36 psychologists) completed the questionnaire. Participants preferred feedback reports on expected treatment outcome that included: (a) both text and images, (b) a continuous outcome or an outcome that is expressed in terms of a probability, (c) specific predictors, and (d) specific advice. For both patients and psychologists, specific predictors appeared to be most important, specific advice was second most important, a continuous outcome or a probability was third most important, and feedback that includes both text and images was fourth in importance. The ranking in importance of both the attributes and the attribute levels was identical for patients and psychologists. This suggests that, as long as the report is understandable to the patient, psychologists and patients can use the same ROM feedback report, eliminating the need for ROM administrators to develop different versions.

  相似文献   
4.
We report three families with arterial aneurysms and dissections in which variants predicted to be pathogenic were identified in SMAD2. Moreover, one variant occurred de novo in a proband with unaffected parents. SMAD2 is a strong candidate gene for arterial aneurysms and dissections given its role in the TGF‐β signaling pathway. Furthermore, although SMAD2 and SMAD3 probably have functionally distinct roles in cell signaling, they are structurally very similar. Our findings indicate that SMAD2 mutations are associated with arterial aneurysms and dissections and are in accordance with the observation that patients with pathogenic variants in genes encoding proteins involved in the TGF‐β signaling pathway exhibit arterial aneurysms and dissections as key features  相似文献   
5.
A histopathological classification system for ANCA-associated vasculitis was recently published, but whether this system predicts renal outcome requires validation. Here, we analyzed data from 164 consecutive patients with biopsy-proven renal involvement of ANCA-associated vasculitis. The ANCA-associated GN (AGN) classification categorizes patients as having focal, mixed, crescentic, or sclerotic GN. Five-year renal survival rates by categories of the AGN classification scheme were 91% for focal, 69% for mixed, and 64% for crescentic (log-rank P<0.0001). Only one patient was classified as sclerotic. Furthermore, the percentage of normal glomeruli found on biopsy estimated renal survival with the same precision as did the AGN classification scheme. Patients classified as crescentic or mixed, however, had worse survival when the percentage of normal glomeruli was <25%. In conclusion, the AGN classification for renal biopsy specimens is a practical and informative scheme with which to categorize patients with ANCA-associated vasculitis, but adding the percentage of normal glomeruli to the system seems to improve its predictive value.Necrotizing crescentic GN is a common feature in ANCA-associated vasculitis (AAV).1 Histologically, renal lesions in AAV are characterized by cellular crescents, fibrinoid necrosis, and interstitial inflammation. Recently, an international vasculitis working group proposed a histopathologic classification of GN in patients with AAV to assess its predictive value for renal survival.2To validate the ANCA-associated GN classification system (AGN classification), we scored all AAV renal biopsy specimens from patients with AAV who participated in the Limburg Renal Registry, a prospective renal biopsy study on glomerular diseases.3,4 The database was searched for patients with pauci-immune necrotizing crescentic GN.5Two hundred twenty-one consecutive patients who underwent renal biopsy between January 1, 1979, and August 31, 2011, in the province of Limburg, The Netherlands, were identified as having pauci-immune necrotizing crescentic GN. Eight of these patients were excluded for concomitant renal disease (six with diabetic nephropathy and two with thin glomerular basement membrane nephropathy). Forty-nine patients were excluded because <10 glomeruli were found in the renal biopsy specimen.2Thus, 164 patients with a mean age ± SD of 61.0±14.6 years were included (113 men and 52 women) with a mean follow-up of 8.5 years (range, 1 day–33 years). Eighty-three patients were positive for proteinase-3 ANCA and 81 were positive for myeloperoxidase (MPO) ANCA. Mean baseline serum creatinine was 349.7 ± 242.6 µmol/L, and median baseline proteinuria was 1.3 g per 24 hours (range, 0–11).Before 2000, patients received corticosteroids in combination with oral cyclophosphamide. Since 2000, all patients have been treated according to the European League Against Rheumatism (EULAR) guidelines:5 induction therapy with steroids and oral cyclophosphamide, 2 mg/kg per day, over 3–6 months and maintenance therapy with azathioprine and low-dose corticosteroids.6 Since 2009, induction therapy consisted of corticosteroids with intravenous cyclophosphamide at a dose of 15 mg/kg per cycle over three to six pulses with 2-week intervals, or with oral cyclophosphamide.7 Patients with a serum creatinine >500 μmol/L or alveolar lung hemorrhage at the time of renal biopsy were considered to have severe or life-threatening vasculitis and received 1000 mg of prednisolone per day for 3 days or plasma exchange in addition to the standard treatment as described above.5Eighty-one (49.4%) biopsy specimens were classified as focal, 43 (26.2%) as crescentic, and 39 (23.8%) as mixed. Only one biopsy specimen was classified as sclerotic (i.e., >50% sclerotic glomeruli). Baseline characteristics (at the time of renal biopsy) are presented in
Characteristic at Time of Renal BiopsyFocal (n=81)Crescentic (n=43)Mixed (n=39)Sclerotic (n=1)All (n=164)
Age60.1±15.662.0±14.461.5±13.175.960.9±14.6
Men/women (n/n)54/2733/1025/141 (male)113/51
Histologic features (%)
 Normal72.9±15.617.6±11.929.7±13.633.348.0±28.9
 Cellular crescents17.2±10.266.7±29.530.6±13.416.733.5±20.9
 Obliterated4.6±7.07.5±10.215.0±13.6507.9±10.6
Serum creatinine269.8±210.3487.0±249.5363.4±235.3375.0349.5±243.3
eGFR39.3±29.416.8±14.724.3±19.514.629.7±25.8
Proteinuria0.7 (0.1–10.5)1.3 (0.1–8.7)2.0 (0.2–11.0)2.41.3 (0–11)
MPO/PR3 ANCA49/3217/2616/230/181/83
Open in a separate windowValues expressed with a plus/minus sign are the mean ± SD. PR3, proteinase-3.The 5-year renal survival rates (censored for death) per classification group were 91% for the focal group, 64% for the crescentic group, and 69% for the mixed group (log-rank analysis P<0.0001) (Figure 1). Renal survival did not significantly differ between the crescentic and the mixed groups (P=0.64).Open in a separate windowFigure 1.Renal survival, as shown by AGN classification, is best in the focal group (log rank analysis P<0.0001). The sclerotic group was left out because it consisted of only one patient.Data on renal function during follow-up were available from 96 patients who had not died (n=37), were not dependent on renal replacement therapy (n=16), and were not lost to follow-up (n=14). At 1-year follow-up, mean estimated GFRs (eGFRs) were 54.5±20.9 ml/min per 1.73 m2 in the focal group (n=56), 41.0±21.1 ml/min per 1.73 m2 in the crescentic group (n=17), and 36.7±18.6 ml/min per 1.73 m2 in the mixed group (n=23) (focal versus crescentic, P=0.02; focal versus mixed, P=0.007; crescentic versus mixed, P=0.41). eGFR data at 2 years of follow-up were available from 83 patients: 53.5±20.8 ml/min per 1.73 m2 in the focal group (n=54) , 38.8±22.3 ml/min per 1.73 m2 in the crescentic group (n=12), and 38.3±16.0 ml/min per 1.73 m2 in the mixed group (n=17) (focal versus crescentic, P=0.03; focal versus mixed, P=0.007; crescentic versus mixed, P=0.95).The 1- and 5-year patient survival rates were 82.9% and 73.1% for the focal group, 61.5% and 52.3% for the crescentic group, and 87.8% and 68.3% for the mixed group (P=0.06).When renal biopsy specimens were grouped according to the percentage of normal glomeruli, we found 5-year renal survival rates of 93.2% for the group with >75% normal glomeruli, 81.0% for the group with 50%–75% normal glomeruli, 80.7% for patients with 25%–50% normal glomeruli, and 57.8% for the group with <25% normal glomeruli (log rank analysis P<0.0001) (Figure 2). Importantly, renal survival was significantly worse in patients classified as crescentic or mixed when the percentage of normal glomeruli in the renal biopsy was <25% (P=0.04) (Figure 3).Open in a separate windowFigure 2.Renal survival, as shown by percentage of normal glomeruli in the renal biopsy specimen, is best in patients with ≥75% and worst in patients with ≤25% normal glomeruli in the renal biopsy specimen (log rank analysis P<0.0001).Open in a separate windowFigure 3.Renal survival of patients classified as crescentic and mixed by the AGN classification is worse in patients with <25% normal glomeruli (log rank analysis P=0.04).We confirmed the study by Berden et al. by showing that patients with a renal biopsy specimen classified as focal GN had the best renal survival. Several important differences between our study and that of Berden et al.2 were observed.First, only one patient could be classified in the sclerotic group. For all other biopsy specimens, the percentage of sclerotic glomeruli was <50%. In contrast, Berden et al. classified 13 of their 100 patients (13%) in the sclerotic group. In our study, we sought to make an early diagnosis of GN in patients with erythrocyturia and proteinuria,3,4 possibly resulting in fewer sclerotic glomeruli.Of note, however, our patient population was similar to the patients in Berden and colleagues'' study in terms of age and distribution of proteinase-3 ANCA versus MPO ANCA.2Second, patients who were classified in the crescentic group had a similar renal survival compared with patients in the mixed group. In contrast, Berden et al. found a better renal survival in patients in the crescentic group than in the mixed group. Our finding that mixed and crescentic patients had similar renal outcomes was true not only for patients treated before 2000, when EULAR guidelines for treatment were not yet available, but also for patients treated after 2000, when plasma exchange, in addition to cyclophosphamide and oral steroids, was introduced in Limburg for the most severely affected patients.5 Recently, Chang et al. also found that renal outcome of mixed patients and crescentic patients was similar.8 Most patients in their study were MPO ANCA positive. This finding differs from the study of Berden et al.2 and our study, demonstrating that the AGN classification system has predictive value irrespective of the ANCA phenotype.As shown in the past, the percentage of normal glomeruli strongly predicts renal survival.9 Indeed, in our patients who were classified in the crescentic group, a somewhat lower percentage of normal glomeruli was found compared with the mixed group: 17.6% normal glomeruli and 29.7%, respectively. This probably explains the difference between our study and the one by Berden et al.Most important, patients classified as crescentic and mixed in our study had a significantly worse renal survival when the percentage of normal glomeruli was <25%. Therefore, we suggest that renal pathologists mention the specific percentage of normal glomeruli found in the renal biopsy specimen in addition to classification into one of the four AGN categories. A biopsy sample would then, for example, be described as follows: “crescentic, 30% normal glomeruli.”The AGN classification is based on glomerular features only. Interstitial features, however, have been included in earlier histopathologic classifications.9 Recently, Berden et al.10 showed that tubular atrophy and tubulitis predict eGFR at 12 months in patients with ANCA-associated GN treated with a rituximab-based regimen. This finding indicates that interstitial changes in the renal biopsy specimen may have predictive value in addition to glomerular features.In summary, we confirmed that the AGN classification system is a useful tool with a good predictive value for renal survival. Importantly, the nephropathologist can optimize the system by mentioning the specific percentage of normal glomeruli in the biopsy specimen.  相似文献   
6.
AKN-028 induces cell cycle arrest,downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia     
Anna Eriksson  Antonia Kalushkova  Malin Jarvius  Riet Hilhorst  Linda Rickardson  Hanna Göransson Kultima  Rik de Wijn  Liesbeth Hovestad  Mårten Fryknäs  Fredrik Öberg  Rolf Larsson  Vendela Parrow  Martin Höglund 《Biochemical pharmacology》2014
  相似文献   
7.
A mutation update on the LDS‐associated genes TGFB2/3 and SMAD2/3          下载免费PDF全文
Hiroko Morisaki  Gretchen MacCarrick  Mark Lindsay  David Liang  Sarju G. Mehta  Jennifer Hague  Judith Verhagen  Ingrid van de Laar  Marja Wessels  Yvonne Detisch  Mieke van Haelst  Annette Baas  Klaske Lichtenbelt  Kees Braun  Denise van der Linde  Jolien Roos‐Hesselink  George McGillivray  Josephina Meester  Isabelle Maystadt  Paul Coucke  Elie El‐Khoury  Sandhya Parkash  Birgitte Diness  Lotte Risom  Ingrid Scurr  Yvonne Hilhorst‐Hofstee  Takayuki Morisaki  Julie Richer  Julie Désir  Marlies Kempers  Andrea L. Rideout  Gabrielle Horne  Chris Bennett  Elisa Rahikkala  Geert Vandeweyer  Maaike Alaerts  Aline Verstraeten  Hal Dietz  Lut Van Laer  Bart Loeys 《Human mutation》2018,39(5):621-634
The Loeys–Dietz syndrome (LDS) is a connective tissue disorder affecting the cardiovascular, skeletal, and ocular system. Most typically, LDS patients present with aortic aneurysms and arterial tortuosity, hypertelorism, and bifid/broad uvula or cleft palate. Initially, mutations in transforming growth factor‐β (TGF‐β) receptors (TGFBR1 and TGFBR2) were described to cause LDS, hereby leading to impaired TGF‐β signaling. More recently, TGF‐β ligands, TGFB2 and TGFB3, as well as intracellular downstream effectors of the TGF‐β pathway, SMAD2 and SMAD3, were shown to be involved in LDS. This emphasizes the role of disturbed TGF‐β signaling in LDS pathogenesis. Since most literature so far has focused on TGFBR1/2, we provide a comprehensive review on the known and some novel TGFB2/3 and SMAD2/3 mutations. For TGFB2 and SMAD3, the clinical manifestations, both of the patients previously described in the literature and our newly reported patients, are summarized in detail. This clearly indicates that LDS concerns a disorder with a broad phenotypical spectrum that is still emerging as more patients will be identified. All mutations described here are present in the corresponding Leiden Open Variant Database.  相似文献   
8.
Physical beauty: only skin deep?     
Hilhorst MT 《Medicine, health care, and philosophy》2002,5(1):11-21
Personal appearance and physical beauty are becoming increasingly important in our societies and, as a consequence, enter into the realm of medicine and health care. Adequate and just health care policies call for an understanding of this trend. The core question to be addressed concerns the very idea of beauty. In the following, a conceptual clarification is given in terms of beauty's meaning, value and function (i.e. beauty that is used instrumentally, and beauty that is attained). Furthermore, some relevant distinctions are drawn between physical and artistic beauty, and physical beauty in a human sense. The core idea for this is formed by a Kantian notion of the beauty concept. It is argued that beauty judgements should be understood as relative to persons and their contexts. Physical beauty should be taken seriously when it is understood in this deeper sense of being related to the shaping of a person's identity.  相似文献   
9.
Cryopreservation of ovarian tissue; now is the time for ethical considerations     
Hilhorst JA  Braat DD  Goverde HJ  ten Have HA 《Nederlands tijdschrift voor geneeskunde》2000,144(15):695-698
The development of ovarian tissue cryopreservation will expand the range of clinical applications in reproductive medicine. This emerging technology may have beneficial opportunities for patients, particularly in oncology, as well as for the process of oocyte donation. However, it will also lead to new moral problems requiring critical reflection concerning the criteria for tissue banking and future clinical applications. Because cryopreservation of ovarian tissue nowadays is the focus of experimental research, technology assessment is currently appropriate, anticipating introduction into clinical practice. Specific guidelines, developed by the medical profession in cooperation with ethicists and lawyers can contribute to prudent clinical use.  相似文献   
10.
Starting a crossover kidney transplantation program in the Netherlands: ethical and psychological considerations   总被引:8,自引:0,他引:8  
Kranenburg LW  Visak T  Weimar W  Zuidema W  de Klerk M  Hilhorst M  Passchier J  IJzermans JN  Busschbach JJ 《Transplantation》2004,78(2):194-197
On April 15th, 2003, the first crossover kidney transplantation took place in The Netherlands. In September of the same year, a national database was established to facilitate kidney exchange between two donor-recipient couples. During 2004, kidneys from living donors will be exchanged between the seven university medical centers in The Netherlands. One of the conditions for successfully implementing this program was the need to address the ethical and psychologic implications involved. In this article we will discuss the ethical and psychologic considerations that are accompanying the practical preparations for the first Dutch crossover transplantation program. We identified five topics of interest: the influence of "donation by strangers" on the motivation and willingness of donor-patient couples, the issue of anonymity, the loss of the possibility of "medical excuses" for unwilling donors, the view that crossover is a first step to commercial organ trade, and the interference with existing organ donation programs. We concluded that whether viewed separately or in combination, these issues do not impede the efficient organization of a crossover program or raise worrying ethical issues.  相似文献   
1 [2] [3] [4] [5] [6] [7] 下一页 » 末  页»
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号